The specific binding of NEO-201 to tumor-associated variants of CEACAM5 and CEACAM6 could be due to post-translational modifications (i.e., attachment of O-glycans to the protein structure of those proteins) occurring during the process of carcinogenesis. The gene discussed is CEACAM5; the disease is neoplasm.